Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine Extension Study in Chronic Hepatitis B
NCT00124241Phase 2Completed
- Sponsor
- Novartis
- Primary completion
- Feb 2003
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 4
01
Overview
A Phase 2 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Novartis. Status: completed.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00124241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00124241.